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Human kidney 293 TSA cells were transfected by a calcium phosphate method with human formylpeptide and CSa re.~ptor cDNAs with higli 
efficiency. Formylpeptide r ceptor positive transfectants expressed a total of 968.000 ± 34,000 receptors per cell with two affinity stat©s (Kds of 
ca. 0.43 nM and 39 riM), which in the presence of 100/~M GTP~,S decreased by ca. 4-fold the number of high-affinity sites. The ligand binding 
pharmacology ofcloned and expressed formylpeptide r~ptors were indistinguishable from endogenous receptors on human eutrophils. Expres.~d 
formylpcptide and CSa receptors were functionally active in mobilizing intracellular calcium via a pertussis toxin sensitive mechanism with an £Ds0 
for formylpeptid¢ ofca. 0.5-1.0 nM. This expression system, in which receptor expression can be monitored by flow cytometrie methods and in 
which intracellular calcium responses are measurable, unlike in the more popular COS-7 cell expression system, will provide a useful basis for the 
analysis of chemoattractant receptor structure-function relationships. 
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1. INTRODUCTION 
The ability of phagocytic leukocytes (polymorpho- 
nuclear leukocytes and macrophages) to accumulate 
and become activated at sites of inflammatory eactions 
is a prerequisite for their r~;e in host defense. The 
normal functioning of phagocytes in inflammation re- 
quires the coordinate regulation of migratory vs. cyto- 
toxic activities. Phagocytes migrate along gradients of 
chemoattractants produced by humeral and cellular im- 
mune responses. At higher concentrations, chemoat- 
tractants have the ability to stimulate the cells' cytotoxic 
responses. Defined chemotactic factors include C5a, a 
complement proteolytic fragment, leukotriene B4 
(LTB4), an araehidonate metabolite, platelet-activating 
factor (PAF), certain products of bacterial protein syn- 
thesis (i.e. formylmethionyl peptides) and a family of 
chemotactic cytokines including interleukin-8 (reviewed 
in [1,2]). 
The best characterized chemotactic factor receptor is 
the one which binds formylpeptides. While much is 
known of how this receptor initiates cellular activation 
[1,2], the precise mechanisms by which chemoattractant 
r~eptors initiate migratory versus cytotoxie activities 
remains to be determined. 
The availability of cloned eDNAs encoding chemoat- 
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tractant receptors will provide tools for genetic 
approaches to determining their structure-function re-
lationships and means of receptor desensitization. To
this end we report he development of a highly efficient 
transient eDNA expression system in which cloned and 
expressed ¢hemoattractant r~¢ptors are functionally 
competent to evoke ligand-mediated intracellular 
calcium mobilization. In addition, the binding pharma- 
cology and the ability to couple to pertussis toxin sensi- 
tive G proteins mimics endogenous ehemoattraetant re- 
ceptors on human neutrophils. 
2. MATERIALS AND METHODS 
2.1. Materials 
PMA, norepinephrine, carbachol, CSa, fMet-Mct-Mct, fMet-Phe, 
Met-Leu-Phe, fMet, and fluoreseein isothioeyanate (FITC) from 
Sigma. fMet-Leu-Phe and fNle.Leu-Phe-Nle-T~,r-Lys from Peninsula 
Laboratories (Burlingame, CA). FITC-fMet-Lau-Phe and lndo-I AM 
t'rom Molecular Probes Inc. (Eugene, OR). Adenosine triphosphate 
(ATP) from Pharmaeia/LKB. [~H]FMLP (53.6 Ci/mmol) and 
~[3:P]NAD from New England Nuclear. Pertussis toxin from List 
Biological Laboratories (Campbell, CA). Tissue culture media from 
Gib¢.o. 
2.2. Celts~cell cultureltransfection 
Adenovirus type $ transformed human embryonic kidney 293 cells 
from American Type Culture Collection (ATCC no. CRL 1573). TSA 
cells (a elonal variant of 293 ceils stably expr~sing viral large T 
antigen) kindly provided by Dr G. Rice° ~encntceh inc. C.¢Iis were 
maintained in DMEM/FI2 (50:50) supplemented with 10% fetal 
bovine serum, 2 mM glutamine and containing penicillia/strepto- 
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mycin. Calcium phosphate mediated transfection f cells was carried 
out as described [3] using 8-9/J$ of CsCl.parifled plasmld DNA as a 
calcium phosphate pr~ipitatc per 60 mm plate, Cells were exposed to 
DNA for 18 h, glycerol shocked for 15 s and analyzed 48 h later, 
Human neutrophils were isolated from peripheral blood of normal 
volunteers as described [4], 
2,3, Cytosolic calcium measurements 
Forty-eight hours after glycerol shocking transfected cells were re- 
moved from cell culture dishes with Versene (Gibeo), washed once 
with 10 mM HEPES-buffered Hanks balanced salt solution (HHBSS) 
at room temperature and resuspended in 1,2 ml HHBSS (-5-6 x 10~/ 
ml). Cells were loaded with 1 /.tM lndo-1 AM for 20 rain at room 
temperature, washed twice with HHBSS, resuspended in 1,2 ml 
HHBSS and placed in a cuvette. The cuvette was placed into a heated 
(37°C) cuvette holder of a Perkin-Elmer fluorescence spcetrophoto. 
meter (Model 650-19), Calcium analyses were carried out after equi- 
libration of the cells to 37°C (5 mint with an excitation wavelength of 
335 nm and an emission wavelength of 405 rim, Maximal and minimal 
fluorescence were determined in the presence of 0.02% digitonin and 
20 mM Tris-HCl pH 8, 5 mM EGTA respectively, lntracellular 
calcium levels were measured using the following formula: [Ca:']L = 
K~ (F-F~,,,/Fm.,-F) [5], 
2.4. DNA clonmg/plasmM constructions 
Reverse transcription PCR of differentiated HL.60 cell mRNA to 
obtain formylpeptide r ceptor encoding eDNA was carried out essen- 
tially as described [6] using antisense primer (5'.CTI'rGCCTG. 
TAACGCCACCTC.3') and amplified with antisense and sense 
primer (5'-ATGGAGACAAATTCCTCTCTCC-3') using VENT po- 
lymerase (New England Biolabs) for 29 cycles (denaturation at 94°C, 
30 s. annealing at 55°C, 30 s and extension at 72°C, 30 st. The resulting 
eDNA fragment was labeled by nick translation and used to screen 
a Zgtl0 HL-60d library [7] under low stringency (6 x SSC, 0,25,% 
non-fat dry milk at 42°C) with washing in 2 x SSC, 0.1% SDS at 48"C. 
Formylpeptide r ceptor clones were confirmed by double stranded 
DNA sequencing as described [8]. The coding region of the formyl- 
peptide receptor eDNA from a receptor positive clone was generated 
by PCR to contain a unique EcoRI site immediately 5'of the start 
codon and a Hindlll site immediately 3'to the stop codon using the 
cloning primers described above which had an additional 12 bases at 
their $' end encoding EcoR 1 and Hindlll sites respectively, The EcoRI/ 
Hindlll digested PeR-generated receptor eDNA was then direction- 
all2,' cloned into Ecagl/Hlndl[i cut pgK5 plasmid DNA [9], A 2,1 kb 
Ecogl.digested DNA fragment (25 bp of 5'-untranslated sequence 
and ca, 1,0 kb of Y-untranslated sequence) ncoding the CSa chemoat- 
tractant receptor [101 was inserted into the same pRK5 vector. 
2,5, Preparation of membranes 
Membranes from chemoattractant receptor transfected TSA cells 
were prepar~l as described for neutrophil membranes [4], 
2.6. ADP-ribos),lation fmembranes 
Pertussis toxin catalyzed ADP-ribosylation ofcell membranes was 
carried out as described [11] using 50/.tg of membrane protein in a 
reaction mixture containing 0.1% Lubrol, 10/.tM NAD, ,v[nP]NAD 
(5,000 cprrVpmol) without guanine nucleotides for 30 rain at 30°C, 
2,7, Binding assays 
Flow eytometric analysis of FMLP or CSa binding to transf¢¢ted 
cells was carried out using 10 nM FITC-FMLP and 5 nM FITC-C5a 
prepared as described [12], Cells were ineubat~l with fluoreseeinated 
ligands in HHBSS for 2 h at 4°C, washed and analyzed on an Epics 
753 flow cytometer. Radioligand binding of [~H]FMLP to intact cells 
was carried out on 200,ul cell aliquots (2 x l0 W cells) in HHBSS at 4*C 
for 2 h, Cells were collected by vacuum filtration on Whatman GFC 
filters, washed 5 times with cold HHBSS and dried filters counted in 
r~intillation fluid. Radioligand binding to membranes was carried out 
as described above xcept using 10 mM HEPES pH 7,2, 5 mM MgCl:, 
1 mM EGTA. 1 mM DTT as buffer and incubating for 1 h at room 
temperature [13], Binding parameters were analyzed by Seatfit com. 
purer analysis using a nonlinear least squares curve fitting [14]. 
3. RESULTS 
3.1. Cloning and expression of  formylpeptide receptor 
eDNA 
eDNA clones encod ing the formylpept ide  receptor  
reported by Bou lay  et el. [15] were isolated from a Agt l0 
l ibrary const ructed f rom mRNA of  d ibutyry l  cyclic 
AMP d i f ferent iated HL-60  cells (HL-60d).  Screening 
was carr ied out  using o l igonucleot ide pr imers (24-mer) 
complementary  to the first 8 amino  acids (5" pr imer)  and 
COOH-termina l  8 amino  acids (3' pr imer)  o f  the 
reported receptor  sequence [15] were used in a reverse 
t ranscr ipt ion po lymerase  chain react ion (RT-PCR)  with 
mRNA o f  HL -60d cells as a template,  The result ing 
eDNA f ragment  was used to screen the l ibrary under 
low str ingency. Receptor  c lones were selected, f rom sec- 
ondary  screens using end- labeled 3' pr imer  under  high 
str ingency. Four  o f  n ine clones were identical  to the 
previously reported fo rmylpept ide  receptor  eDNA se- 
quence [15], The cod ing  region f rom one o f  these four 
clones was t rans ient ly  expressed in TSA human em- 







Coi ls  _ 
o ~R 
Rt- 
FiB. 1. Analysis by flow ¢ytometry of formylpeptid¢ and C5a recepter 
expression on transfected cells. Human kidney TSA cells were trans- 
fected with formylpeptide r ceptor eDNA (R+) or plasmid vector 
alone (C) (panel A) and with CSa receptor eDNA (panel B), Forty- 
eight hours post-transfection cells, were incubated with 10 nM of 
fluorescein-conjugated fNle-Leu-Phe-Nle-Tyr-Lys or 5 nM fluores- 
cein-eonjugated CSa at 4°C for 2 h. Cells were analyzed by FAC$ a~ 
described in section 2, In the above representative fluorescence 
patterns, 44,% of formylpeptlde r ceptor transfected TSA cells and 
35,% of CSa receptor transfected cells arc expressing receptor. 
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transfection. Transfection efficiency was measured by 
flow cytometry using FITC-fNle-Leu-Phe-Nle-Tyr-Lys. 
Approximately 40-55% of transfected cells expressed 
formylpeptide r ceptors (Fig. I A). 
3.2. Expression of CSa receptor eDNA 
The EcoRI eDNA fragment encoding the CSa che- 
moattractant receptor [10], inserted into the pRK5 
vector, was transfected into TSA cells in the same 
manner as the cloned formylpeptide receptor eDNA. 
Flow cytometry measurements u ing FITC-C5a indi- 
cated approximately 35--40% of transfected cells ex- 
pressing CSa receptors (Fig. IB). 
3.3. Binding specificity of cloned and expressed formyl- 
peptide receptors: comparison with endogenous neu. 
trophil formylpeptide r ceptors 
The ability of various N-formylated peptides to com- 
pete with [3H]FMLP binding to expressed formyl- 
peptide receptors was compared with endogenous for- 
mylpeptide receptors on human neutrophils (Fig. 2). 
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Fig, 2, Comparison of the specificity of ['~H]FMLP binding to £ormyl- 
peptide receptors on human neutrophils vs, receptor transfccted TSA 
cells. Formylpeptlde receptor transfected TSA cells (panel A) and 
with 5 nM [ H]FMLP in human eutrophils (panel B) were incubated 
the presence of various concentrations of fMet-Leu. Ph, ~. (D), fNle- 
Lea-Phe-Nle-Tyr-Lys (<0, fMet-Met-Met (©), fMet-Phe (z~), Met- 
Leu-Phe (~7) and fMct (<). Specific binding was calculated and ex- 
pressed as the percent of [3H]FMLP binding in the absence of any 
competing peptide. Each value represents he mean of triplicate de- 
termination.~, 
ing to expressed formylpeptide r ceptors was fNle-Leu- 
Phe-Nle-Tyr-Lys > fMet-Leu-Phe > fMet-Met-Met > 
fMet-Phe > Met-Leu.Phe > fMet (Fig. 2A). This bind. 
ing specificity profile was indistinguishable from that 
observed for the native receptor on human neutrophils 
(Fig. 2B). 
3.4. Effect of guanine nucleotide on equilibrium binding 
of FMLP to formylpeptide r ceptor transfected cell 
membranes 
Membranes from form~,lpeptide r ceptor transfected 
TSA cells were incubated with [~H]FMLP and specific 
binding plotted by Scatchard analysis [16]. The total 
receptor concentration was ca. 2.3 pmol/mg of 
membrane protein which corresponded to 968,000 + 
34,000 receptors per receptor expressing cell based on 
flow cytometric measurements of transfection efficiency 
(data not shown). Membrane preparations of formyl- 
peptide receptor transfeeted TSA cells showed two af- 
finity states with KdS of 0.43 + 0.1 !nM for the high- 
affinity class and 39 + 7 nM for the low affinity class 
of binding sites (Fig. 3). Binding of [3H]FMLP in the 
presence of I00/~M GTPyS decreased by ca. 4-fold the 
number of high-affinity sites with no effect on total 
receptor number (Fig. 3). 
3.5. Functionality of expressed fortto,lpeptide and CSa 
receptors 
The ability of expressed formylpeptide and C5a re- 
ceptors to transduce ligand-mediated signals was as- 
sayed by examining intracellular calcium mobilization. 
Initial attempts to demonstrate functional transfection 
in COS cells were unsuccessful even though high ef- 
ficiency expression was observed (ca. 30% efficiency, 
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Fig, 3. Scatcltard analysis of specific binding to formylpeptide r ceptor 
transfected TSA cell membranes. [~H]FMLP was incubated at various 
concentrations for l h at 25°C with 13//g of formyl~ptide r ceptor- 
transfccted TSA c¢II membranes per point. Non-spzcific binding was 
determined in the pre~nce of 50.uM unlabeled FMLP and subtracted 
fro,n total blndln8 to determine sp,'~cific binding. Each point is the 
mean of triplicate determinations, A two-site model was determined 
by ScatFit computer analysis. Binding was carried out in the absence 
(D) or presence (e) of 100 uM GTP~3. 
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cells a calcium response to FMLP was evident and oc- 
curred with a peak at ca. 10 s. The maximum increase 
was ca, 100 nM above the basal levels of ca. 150 nM, 
Treatment with 0.5 ~/g/ml pertussis toxin for 4 h in- 
hibited by ca. 70% the calcium response to FMLP (Fig. 
4A). The expressed CSa receptor mobilized intracellular 
calcium with maximal increases of ca. 100 nM that was 
also inhibited by ca. 70% by pertussis toxin pretreat- 
ment (Fig. 4B). Non-transfected cells showed no 
calcium response to either FMLP or C5a (data not 
shown), The specificity of pertussis toxin was indicated 
by the inability of the toxin to affect the response of 
TSA cells to norepinephrine, an ~l-adrenergic agonist 
whose receptor utilizes a pertussis toxin insensitive G 
protein to effect PI hydrolysis and consequent calcium 
mobilization [17] (Fig. 4C). The extent of ribosylation 
by pertussis toxin in TSA cells was determined by in- 
cubating membranes i olated from cells pretreated with 
buffer (Fig. 4D, lane 1) or toxin under the above condi- 
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Fig. 4. Analysis of intraeellular calcium mobilization i  formylpeptide 
and CSa receptor t ansfeeted TSA cells. (A) Formylpeptide receptor 
transfacted cells were incubated in the pr¢~ence (+PT) or absence 
(-PT) of" 0.5 #g/ml pertussis toxin for 4 h at 37°C and subsequently 
loaded with [ndo-l. Cells were then exposed to 10 nM FMLP and 
[Ca=']t measured. (B) As in panel A with Cfa r~'eptor tranff~eted TgA 
cells exposed to 1 nM CSa. (C) As in panel A using non-transl'eeted 
TSA cells exposed to 10 ,uM norepinephrin¢ (Norep.). (D) ADP- 
ribosylation ofTSA cell membranes from control ( ane I) and pertus- 
sis toxin pretreated (0.5//g/ml, 4 h at 37°C) cells (lane 2) by pertussis 
toxin (15 ,ug/ml). Membranes (50 ~g) were incubated as described in 
section 2. An autoradiogram of labelled proteins alter $DS-PAGE is 
presented, molecular weight of size standards in kDa. 
tions (Fig. 4D, lane 2) with pertussis toxin. The extent, 
of ADP-ribosylation of ca. 40--41 kDa product(s) was 
greater than 98% as determined by densitometric scan- 
ning of the autoradiograph. 
4. DISCUSSION 
A transient expression system in which leukocyte che- 
moattractant receptors can be expressed with high ef- 
ficiency and with the ability to initiate biochemical sig- 
nals will allow the rapid analysis of structural receptor 
mutants to delineate structure-function relationships. 
Using calcium phosphate-mediated ransfection of for- 
mylpeptide and CSa receptor cDNAs we obtained high 
transfeetion effieieneies in human embryonic kidney 
cells. To assess the structural integrity of cloned and 
expressed chemoattractant receptors we analyzed the 
binding pharmacology of the formylpeptide r ceptor in 
two ways: (1) by determining the specificity of 
[~H]FMLP binding to receptor transfected cells in paral- 
lel with measurements to human neutrophils and (2) by 
Scatchard analysis of [3H]FMLP binding to formyl- 
peptide receptor transfeeted cells in the presence or 
absence of added guanine nucleotide. The specificity of 
[3H]FMLP binding to formylpeptide receptor trans- 
fectants was indistinguishable from human neutrophils 
with the rank order of potency of various N-formylated 
peptides to compete with FMLP binding being the 
same. Equilibrium binding experiments carried out with 
membranes of formylpeptide receptor transfected TSA 
cells showed two affinity states with Kds of ca. 0.4 nM 
and 39 nM with ca. 25% of the receptors in the high 
affinity state, This compares well with previous binding 
analyses of formylpeptide receptors on human neu- 
trophil membranes (Kas of ca. 0.5 and 20 nM with 25% 
of the receptors being in the high-affinity state [18]). As 
in neutrophils [13], in the presence of guanine nu- 
cleotides there was a ca. 4-fold reduction in high affinity 
receptors measured on membranes of TSA trans- 
fectants with no effect on total receptor number. These 
data suggested a role for G proteins in the regulation 
of formylpeptide receptor affinity [19] and indicate a 
similar degree of G protein association with transfected 
and expressed formylpeptide receptors on TSA cells as 
compared to formylpeptide r ceptors on neutrophils. 
The functionality of cloned and expressed formyl- 
peptide and CSa receptors was assessed by measuring 
the ability of FMLP and CSa to mobilize intracellular 
calcium in receptor transfected cells. The expressed for- 
mylpeptide receptor was capable of mobilizing intracel- 
lular calcium in a dose dependent manner (data not 
shown). The ED~o was ca. 0.5-1.0 nM which compares 
well with the ED~0 found with human neutrophils (ca. 
1 nM [20]). As in the neutrophil, the expressed formyl- 
peptide and CSa receptors are apparently coupled to a 
pertussis toxin sensitive G protein as evidenced by the 
ability of pertussis toxin to inhibit by ca. 70% the 
278 
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calcium responsiveness of cells exposed to FMLP or 
CSa (Fig. 4A and B). While greater than 98% of the 
available pertussis toxin substrate(s) was modified by 
the toxin (Fig. 4D), formylpeptide and CSa receptor 
transfectants still mobilized intracellular calcium, albeit 
at ca. 30% of untreated cells. In pertussis toxin treated 
human neutrophils, a similar degree of ribosylation re- 
sulted in a ca. 90% inhibition of calcium mobilization 
in response to l0 nM FMLP [20]. This observation 
suggests two possibilities: (l) that only very small 
amounts of G protein are necessary to elicit a calcium 
response through association with transfected chemoat- 
tractant receptors. Given the extremely high level of 
receptor expression (ca. 970,000 in transfectants v . ca. 
50,000 in neutrophils [13]) this explanation is certainly 
plausible; (2) that forrnylpeptide and CSa receptors are 
also capable of interacting with a pertussis toxin-in- 
sensitive G protein(s) to mobilize calcium. 
The ability to transiently express both formylpeptide 
and CSa chemoattractant receptors with high efficiency 
in a responsive human cell expression system will now 
allow for the precise delineation of chemoattractant re- 
ceptor structure-function relationships. Genetic ma- 
nipulations of chemoattractant receptors will allow the 
answering of questions not otherwise approachable by 
studying phagocytic leukocytes themselves (i.e. struc- 
ture-function relationships by deleting, adding or 
replacing components). 
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